Adipose tissue macrophages: The inflammatory link between obesity and cancer?

Expert Opinion on Therapeutic Targets

Volumn 19, Issue 4, 2015, Pages 527-538

  Wagner, Marek ^a,b   Samdal Steinskog, Eli Sihn ^a   Wiig, Helge ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adipose tissue; cancer; inflammation; macrophage; obesity

Indexed keywords

ADIPOSE TISSUE; ADIPOSE TISSUE MACROPHAGE; AUTOIMMUNITY; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC INFLAMMATION; CONNECTIVE TISSUE; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MUTAGENICITY; NEOPLASM; NONHUMAN; OBESITY; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; UPREGULATION; ANIMAL; COMPLICATION; DISEASE COURSE; INFLAMMATION; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NEOPLASMS; PATHOLOGY; SPECIES DIFFERENCE;

ADIPOSE TISSUE; ANIMALS; DISEASE PROGRESSION; HUMANS; INFLAMMATION; MACROPHAGES; MICE; MOLECULAR TARGETED THERAPY; NEOPLASMS; OBESITY; SPECIES SPECIFICITY;

EID: 84924898436     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.991311     Document Type: Review

References (96)

1. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55(6):1537-45
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384(9945):766-81
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444(7121):860-7
4. Crunkhorn S. Metabolic disorders: breaking the links between inflammation and diabetes. Nat Rev Drug Discov 2013;12(4):261
5. Ford ES, Li CY, Zhao GX. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2010;2(3):180-93
6. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348(17):1625-38
7. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4(8):579-91
8. Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 2013;339(6117):286-91
9. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7(3):211-17
10. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357(9255):539-45
11. Harvey AE, Lashinger LM, Hursting SD. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci 2011;1229:45-52
12. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-46
13. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112(12):1796-808.
14. Schipper HS, Prakken B, Kalkhoven E, et al. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 2012;23(8):407-15
15. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117(1):175-84.
16. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013;496(7446):445-55
17. Dalmas E, Clement K, Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends Immunol 2011;32(7):307-14
18. Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol 2008;3(5):545-56
19. Amano SU, Cohen JL, Vangala P, et al. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab 2014;19(1):162-71
20. Haase J, Weyer U, Immig K, et al. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia 2014;57(3):562-71
21. Lumeng CN, DelProposto JB, Westcott DJ, et al. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008;57(12):3239-46
22. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25(12):677-86
23. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime rep 2014;6:13
24. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122(3):787-95
25. Biswas SK, Mantovani A. Orchestration of metabolism by macrophages. Cell Metab 2012;15(4):432-7
26. Rodriguez-Prados JC, Traves PG, Cuenca J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 2010;185(1):605-14
27. Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1 beta through HIF-1 alpha. Nature 2013;496(7444):238-42
28. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112(12):1821-30
29. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46(11):2347-55
30. Red Eagle A, Chawla A. In obesity and weight loss, all roads lead to the mighty macrophage. J Clin Invest 2010;120(10):3437-40
31. Kosteli A, Sugaru E, Haemmerle G, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010;120(10):3466-79
32. Lumeng CN, Deyoung SM, Saltiel AR. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol-Endoc M 2007;292(1):E166-74
33. Patsouris D, Li PP, Thapar D, et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008;8(4):301-9
34. Emilsson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature 2008;452(7186):423-8
35. Chen Y, Zhu J, Lum PY, et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008;452(7186):429-35
36. Yang X, Deignan JL, Qi HX, et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet 2009;41(4):415-23
37. Hoda MR, Keely SJ, Bertelsen LS, et al. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg 2007;94(3):346-54
38. Choi JH, Park SH, Leung PC, et al. Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogenactivated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab 2005;90(1):207-10
39. Laud K, Gourdou I, Pessemesse L, et al. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002;188(1-2):219-26
40. Kushiro K, Chu RA, Verma A, et al. Adipocytes promote B16BL6 melanoma cell invasion and the epithelial-to-mesenchymal transition. Cancer Microenviron 2012;5(1):73-82
41. Nunez NP, Oh WJ, Rozenberg J, et al. Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res 2006;66(10):5469-76
42. Hursting SD, Nunez NP, Varticovski L, et al. The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res 2007;67(6):2391-3
43. Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Medicine 2005;11(2):191-8
44. Johnson JA, Gale EA. Diabetes, insulin use, and cancer risk: are observational studies part of the solution-or part of the problem? Diabetes 2010;59(5):1129-31
45. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8(12):915-28
46. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008;454:436-44
47. Herrero L, Shapiro H, Nayer A, et al. Inflammation and adipose tissue macrophages in lipodystrophic mice. P Natl Acad Sci USA 2010;107(1):240-5
48. Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol 2008;3:99-126
49. Wagner M. A dangerous duo in adipose tissue: high-mobility group box 1 protein and macrophages. Yale J Biol Mol 2014;87(2):127-33
50. Arrigo T, Chirico V, Salpietro V, et al. High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children. Eur J Endocrinol 2013;168(4):631-8
51. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004;423(1):12-22
52. Margolin Y, Cloutier JF, Shafirovich V, et al. Paradoxical hotspots for guanine oxidation by a chemical mediator of inflammation. Nat Chem Biol 2006;2(7):365-6
53. Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30(7):1073-81
54. Fleisher AS, Esteller M, Rashid A, et al. Microsatellite instability in IBDassociated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA match repair gene, HMLH1. Gastroenterology 2000;118:A706-A7
55. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004;22(22):4632-42
56. Dick KJ, Nelson CP, Tsaprouni L, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet 2014;383(9933):1990-8
57. Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell 2004;116(4):491-7
58. Oguma K, Oshima H, Aoki M, et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. Embo J 2008;27(12):1671-81
59. van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and Cancer: the Role of Dysfunctional Adipose Tissue. Cancer Epidemiol Biomarkers Prev 2009;18(10):2569-78
60. Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20
61. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol 2004;150:161-71
62. Subbaramaiah K, Howe LR, Bhardwaj P, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res 2011;4:329-46
63. Morris PG, Hudis CA, Giri D, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 2011;4:1021-9
64. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839-49
65. Wagner M, Dudley AC. A three-party alliance in solid tumors: Adipocytes, macrophages and vascular endothelial cells. Adipocyte 2013;2(2):67-73
66. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8
67. Wagner M, Bjerkvig R, Wiig H, et al. Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis 2012;15:481-95
68. Wagner M, Bjerkvig R, Wiig H, et al. Loss of adipocyte specification and necrosis augment tumor-associated inflammation. Adipocyte 2013;2(3):176-83
69. Lin EY, Li JF, Gnatovskiy L, et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006;66:11238-46
70. Faruk Aykan N, Yildiz I, Sen F, et al. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. Med Oncol 2013;30(3):679
71. Mayi TH, Daoudi M, Derudas B, et al. Human adipose tissue macrophages display activation of cancer-related pathways. J Biol Chem 2012;287:21904-13
72. Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002;161:947-56
73. Jung JI, Cho HJ, Jung YJ, et al. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages. Int J Cancer 2014;136:258-70
74. Schledzewski K, Falkowski M, Moldenhauer G, et al. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1(+), F4/80(+), CD11b(+) macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 2006;209(1):67-77
75. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010;31:37-49
76. Seitz CS, Lin Q, Deng H, et al. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci USA 1998;95:2307-12
77. Gapuzan ME, Yufit PV, Gilmore TD. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype. Oncogene 2002;21:2484-92
78. Dajee M, Lazarov M, Zhang JY, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003;421:639-43
79. van Hogerlinden M, Rozell BL, Ahrlund-Richter L, et al. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factorkappaB signaling. Cancer Res 1999;59:3299-303
80. Ricca A, Biroccio A, Trisciuoglio D, et al. relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells. Br J Cancer 2001;85:1914-21
81. Wu D, Molofsky AB, Liang HE, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011;332:243-7
82. Moro K, Yamada T, Tanabe M, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1 (+) lymphoid cells. Nature 2010;463:540-4
83. Nishimura S, Manabe I, Nagasaki M, et al. CD8(+) effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15:914-20
84. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN inflammation 2013;2013:139239
85. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142:687-98
86. Colegio OR, Chu NQ, Szabo AL, et al. Functional polarization of tumour-associated macrophages by tumourderived lactic acid. Nature 2014;513:559-63
87. Shojaei F, Wu XM, Malik AK, et al. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b(+)Gr1 (+) myeloid cells. Nat Biotechnol 2007;25:911-20
88. Johannessen TCA, Wagner M, Straume O, et al. Tumor vasculature: the Achilles' heel of cancer? Expert Opin Ther Tar 2013;17:7-20
89. Ahn GO, Tseng D, Liao CH, et al. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. P Natl Acad Sci USA 2010;107:8363-8
90. Stuehr DJ, Nathan CF. Nitric-oxide - a macrophage product responsible for cytostasis and respiratory inhibition in tumor target-cells. J Exp Med 1989;169:1543-55
91. Wei D, Richardson EL, Zhu K, et al. Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res 2003;63:3855-9
92. Alleva DG, Burger CJ, Elgert KD. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. J Immunol 1994;153:1674-86
93. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 2005;15:277-89
94. DiNapoli MR, Calderon CL, Lopez DM. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J Exp Med 1996;183:1323-9
95. Eubank TD, Roberts RD, Khan M, et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res 2009;69:2133-40
96. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-65